サマリー

スタチンの世界市場 2023-2027
スタチン市場は2022-2027年に26億7661万米ドルの成長が予測され、予測期間中のCAGRは3.36%で加速する。当レポートでは、スタチン市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。高コレステロール血症の有病率の上昇、心血管疾患のリスク因子の増加、一般用医薬品（OTC）に対する消費者の嗜好の高まりが市場を牽引しています。
Technavioのスタチン市場は以下のように区分されている：
エンドユーザー別
- 病院
- 診療所
- その他
タイプ別
- 合成スタチン
- 天然スタチン
地域別
- 北米
- アジア
- ヨーロッパ
- その他の地域（ROW）
本調査では、今後数年間のスタチン市場成長を牽引する主な要因の一つとして、CHDの罹患率の高さを挙げている。また、消費者の健康意識の高まりと先進地域全体の座りがちなライフスタイルは、市場の大きな需要につながる。
スタチン市場に関する本レポートは、以下の分野をカバーしています：
- スタチン市場のサイジング
- スタチン市場の予測
- スタチン市場の産業分析
強固なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories社、Amgen Inc.社、AstraZeneca Plc社、Aurobindo Pharma Ltd.社、Biocon Ltd.社、Concord Biotech Ltd.社、Merck and Co.Inc.、Novartis AG、Pfizer Inc.、Thermo Fisher Scientific Inc.などである。また、スタチン市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/statin-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global statin market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global statin market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 6.4 Clinics - Market size and forecast 2022-2027
o Exhibit 38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Synthetic statin - Market size and forecast 2022-2027
o Exhibit 52: Chart on Synthetic statin - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Synthetic statin - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Synthetic statin - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Synthetic statin - Year-over-year growth 2022-2027 (%)
o 7.4 Natural statin - Market size and forecast 2022-2027
o Exhibit 56: Chart on Natural statin - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Natural statin - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Natural statin - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Natural statin - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 60: Market opportunity by Type ($ million)
o Exhibit 61: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.5 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Canada - Market size and forecast 2022-2027
o Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 111: Abbott Laboratories - Overview
o Exhibit 112: Abbott Laboratories - Business segments
o Exhibit 113: Abbott Laboratories - Key news
o Exhibit 114: Abbott Laboratories - Key offerings
o Exhibit 115: Abbott Laboratories - Segment focus
o 12.4 Amgen Inc.
o Exhibit 116: Amgen Inc. - Overview
o Exhibit 117: Amgen Inc. - Product / Service
o Exhibit 118: Amgen Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 119: AstraZeneca Plc - Overview
o Exhibit 120: AstraZeneca Plc - Product / Service
o Exhibit 121: AstraZeneca Plc - Key news
o Exhibit 122: AstraZeneca Plc - Key offerings
o 12.6 Aurobindo Pharma Ltd.
o Exhibit 123: Aurobindo Pharma Ltd. - Overview
o Exhibit 124: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 125: Aurobindo Pharma Ltd. - Key offerings
o 12.7 Biocon Ltd.
o Exhibit 126: Biocon Ltd. - Overview
o Exhibit 127: Biocon Ltd. - Business segments
o Exhibit 128: Biocon Ltd. - Key offerings
o Exhibit 129: Biocon Ltd. - Segment focus
o 12.8 Concord Biotech Ltd.
o Exhibit 130: Concord Biotech Ltd. - Overview
o Exhibit 131: Concord Biotech Ltd. - Product / Service
o Exhibit 132: Concord Biotech Ltd. - Key offerings
o 12.9 Merck and Co. Inc.
o Exhibit 133: Merck and Co. Inc. - Overview
o Exhibit 134: Merck and Co. Inc. - Business segments
o Exhibit 135: Merck and Co. Inc. - Key news
o Exhibit 136: Merck and Co. Inc. - Key offerings
o Exhibit 137: Merck and Co. Inc. - Segment focus
o 12.10 Novartis AG
o Exhibit 138: Novartis AG - Overview
o Exhibit 139: Novartis AG - Business segments
o Exhibit 140: Novartis AG - Key offerings
o Exhibit 141: Novartis AG - Segment focus
o 12.11 Pfizer Inc.
o Exhibit 142: Pfizer Inc. - Overview
o Exhibit 143: Pfizer Inc. - Product / Service
o Exhibit 144: Pfizer Inc. - Key news
o Exhibit 145: Pfizer Inc. - Key offerings
o 12.12 Thermo Fisher Scientific Inc.
o Exhibit 146: Thermo Fisher Scientific Inc. - Overview
o Exhibit 147: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 148: Thermo Fisher Scientific Inc. - Key news
o Exhibit 149: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 150: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 151: Inclusions checklist
o Exhibit 152: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 153: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 154: Research methodology
o Exhibit 155: Validation techniques employed for market sizing
o Exhibit 156: Information sources
o 13.5 List of abbreviations
o Exhibit 157: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global statin market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Type - Market share 2022-2027 (%)
Exhibits49: Data Table on Type - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Synthetic statin - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Synthetic statin - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Synthetic statin - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Synthetic statin - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Natural statin - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Natural statin - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Natural statin - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Natural statin - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Type ($ million)
Exhibits61: Data Table on Market opportunity by Type ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abbott Laboratories - Overview
Exhibits112: Abbott Laboratories - Business segments
Exhibits113: Abbott Laboratories - Key news
Exhibits114: Abbott Laboratories - Key offerings
Exhibits115: Abbott Laboratories - Segment focus
Exhibits116: Amgen Inc. - Overview
Exhibits117: Amgen Inc. - Product / Service
Exhibits118: Amgen Inc. - Key offerings
Exhibits119: AstraZeneca Plc - Overview
Exhibits120: AstraZeneca Plc - Product / Service
Exhibits121: AstraZeneca Plc - Key news
Exhibits122: AstraZeneca Plc - Key offerings
Exhibits123: Aurobindo Pharma Ltd. - Overview
Exhibits124: Aurobindo Pharma Ltd. - Product / Service
Exhibits125: Aurobindo Pharma Ltd. - Key offerings
Exhibits126: Biocon Ltd. - Overview
Exhibits127: Biocon Ltd. - Business segments
Exhibits128: Biocon Ltd. - Key offerings
Exhibits129: Biocon Ltd. - Segment focus
Exhibits130: Concord Biotech Ltd. - Overview
Exhibits131: Concord Biotech Ltd. - Product / Service
Exhibits132: Concord Biotech Ltd. - Key offerings
Exhibits133: Merck and Co. Inc. - Overview
Exhibits134: Merck and Co. Inc. - Business segments
Exhibits135: Merck and Co. Inc. - Key news
Exhibits136: Merck and Co. Inc. - Key offerings
Exhibits137: Merck and Co. Inc. - Segment focus
Exhibits138: Novartis AG - Overview
Exhibits139: Novartis AG - Business segments
Exhibits140: Novartis AG - Key offerings
Exhibits141: Novartis AG - Segment focus
Exhibits142: Pfizer Inc. - Overview
Exhibits143: Pfizer Inc. - Product / Service
Exhibits144: Pfizer Inc. - Key news
Exhibits145: Pfizer Inc. - Key offerings
Exhibits146: Thermo Fisher Scientific Inc. - Overview
Exhibits147: Thermo Fisher Scientific Inc. - Business segments
Exhibits148: Thermo Fisher Scientific Inc. - Key news
Exhibits149: Thermo Fisher Scientific Inc. - Key offerings
Exhibits150: Thermo Fisher Scientific Inc. - Segment focus
Exhibits151: Inclusions checklist
Exhibits152: Exclusions checklist
Exhibits153: Currency conversion rates for US$
Exhibits154: Research methodology
Exhibits155: Validation techniques employed for market sizing
Exhibits156: Information sources
Exhibits157: List of abbreviations